ADVERTISEMENT
Videos
Improving Survival, Remission Rates Among Patients With AML Treated With New Drug Combo
07/08/2020
Keith Pratz, MD, associate professor of medicine at the Abramson Comprehensive Cancer Center at University of Pennsylvania, discusses the phase III VIALE-A study that demonstrated a reduction in the risk of death in patients with AML among other positive results.
Reference:
Advertisement
Advertisement
Advertisement
Current Issue
September 2024
Volume 21
Issue 3
Advertisement
Advertisement
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter